• For full details of graphics available/in preparation, see Menu -> Planners
News Sport
El gráfico muestra las acciones de Bayer y la cronología de veredictos de jurados sobre herbicidas basados en glifosatos de Bayer
Responsive: View Mobile Version
GN39118ES
EN NL AR DE ES PT

NEGOCIOS

Acciones de Bayer caen en medio del escándalo de cáncer por Roundup

May 15, 2019 - Veredictos adversos de jurados han eliminado más de 40% del valor de
mercado de Bayer desde agosto 2018, con ordenes de pago de daños al grupo farmacéutico alemán por sus herbicidas basados en glifosatos

A jury in California on Monday awarded more than $2bn to a couple who said the weedkiller Roundup was responsible for their cancer.

It is the third time that the German pharmaceutical group Bayer has been ordered to pay damages over its glyphosate-based herbicide.

Bayer, which acquired Roundup maker Monsanto for $63 billion last year, denies the allegations, saying decades of studies and regulatory approvals have shown glyphosate and Roundup to be safe for human use.

But the company faces similar U.S. lawsuits by more than 13,400 plaintiffs and shareholders have rebuked Bayer’s top management over its handling of the Monsanto acquisition and the litigation it inherited.

Sources
PUBLISHED: 15/05/2019; STORY: Graphic News; PICTURES: Getty Images
Advertisement